Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2010
06/08/2010US7732179 Mutants of pyrroloquinoline quinone dependent soluble glucose dehydrogenase
06/08/2010US7732178 Laccase enzymes and their uses
06/08/2010US7732177 Inactive 2',5' Oligo-adenylate synthetase (OAS) for use as viricidal and antitumor therapeutic
06/08/2010US7732176 3-phosphoglycerate dehydrogenase having a reduced feedback inhibition by L-serine; produced by deleting at least 79 amino acids at the C terminus of the wild-type serA sequence
06/08/2010US7732175 Method and circuit arrangement for treating biomaterial
06/08/2010US7732172 Process for producing glycolic acid from formaldehyde and hydrogen cyanide
06/08/2010US7732170 Enhanced production of lipids containing polyenoic fatty acid by very hugh density cultures of eukaryotic microbes in fermentors
06/08/2010US7732167 Interferon-α/β binding fusion proteins and therapeutic uses thereof
06/08/2010US7732165 recombinant polynucleotide that encodes a cell surface polypeptide comprising a biomolecule partition motif that can direct targeting of intracellular polypeptides to and through membranes, including cell surface membranes
06/08/2010US7732164 Method for producing α-1, 6-branched α-1, 4-glucans from sucrose
06/08/2010US7732163 Extracellular serine protease
06/08/2010US7732161 fermentation method that converts hydroxymethylglutaryl-CoA to L-mevalonic acid and eventually to isoprenoids (farnesol and geranylgeraniol )
06/08/2010US7732150 matrix of proteins encapsulating a genome encoding first and second polypeptides of an autogenously assembling receptor and a receptor comprised of the two polypeptides surface-integrated into the matrix via a lambdoid phage tail protein matrix anchor domain fused to at least one of the polypeptides
06/08/2010US7732144 assessing levels of expression of Thymidylate Synthase (TS) and Excision Repair Cross-Complementing (ERCC1) mRNA obtained from fixed or fixed and paraffin-embedded (FPE) tumor cells
06/08/2010US7732143 characterized by substantial impairments of the genome, either in its structure, deletion or translocation and methods which allow genes to be located and mapped rapidly
06/08/2010US7732133 For cell-free detection of phenotypes linked to cell proliferation; drug screening; kits
06/08/2010US7732130 Immunoprotective influenza antigen and its use in vaccination
06/08/2010US7732129 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation
06/08/2010US7731975 Chimeric filovirus glycoprotein
06/08/2010US7731974 a mutant rhabdovirus having one or more mutation in a gene encoding a protein involved in blocking nuclear transport of mRNA or protein in an infected cells; capable of triggering the anti-viral systems of normal host cells; anticarcinogenic agent; vaccine adjuvant, vaccine vector
06/08/2010US7731970 Variants of the major allergen Phl p 1 from timothy grass
06/08/2010US7731961 Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8
06/08/2010US7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
06/08/2010US7731653 System and method for genetically treating cardiac conduction disturbances
06/08/2010CA2457072C Zone heating of specimen carriers
06/08/2010CA2422295C A gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene
06/08/2010CA2368135C Xylo-lna analogues
06/08/2010CA2363991C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
06/08/2010CA2322019C Mass spectrometric methods for biomolecular screening
06/08/2010CA2294045C Gene encoding a protein having aurone synthesis activity
06/08/2010CA2266342C Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
06/08/2010CA2230435C Production of l(+)-lactate
06/08/2010CA2210956C Method for preparing a recombinant adenovirus genome
06/08/2010CA2158047C Allergenic protein and peptides from house dust mite and uses therefor
06/08/2010CA2144475C Polyamide-oligonucleotide derivatives, their preparation and use
06/08/2010CA1341606C Activation of nf-kb precursor
06/05/2010CA2645883A1 Selective detection of human rhinovirus
06/03/2010WO2010062966A2 Methods for inducing mixed chimerism
06/03/2010WO2010062951A2 Animal model for osteoarthritis and intervertebral disc disease
06/03/2010WO2010062859A2 Recombinantly expressed plasmodium celtos antigen and methods of use thereof
06/03/2010WO2010062817A1 RNA INTERFERENCE MEDIATED INHIBITION OF EPITHELIAL SODIUM CHANNEL (ENaC) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
06/03/2010WO2010062781A2 Methods, kits, and reaction mixtures for high resolution melt genotyping
06/03/2010WO2010062779A2 Modified dna polymerases
06/03/2010WO2010062777A2 Modified type a dna polymerases
06/03/2010WO2010062776A2 Chimeric dna polymerases
06/03/2010WO2010062775A2 Methods for detecting modification resistant nucleic acids
06/03/2010WO2010062756A2 Preventing and treating sepsis
06/03/2010WO2010062751A1 Methods of enhancing the resistance of plants to bacterial pathogens
06/03/2010WO2010062707A1 Methods and compositions for producing carbon-based products of interest in micro-organisms
06/03/2010WO2010062604A2 Models of thrombotic thrombocytopenic purpura and methods of use thereof
06/03/2010WO2010062396A2 Virus like particle compositions and methods of use
06/03/2010WO2010062279A1 Method for producing human recombinant insulin
06/03/2010WO2010062240A1 Vegetabile material, plants and a method of producing a plant having altered lignin properties
06/03/2010WO2010061997A1 Method for screening anticancer agent or sip1/zeb2 inhibitor using integrin alpha 5
06/03/2010WO2010061996A1 Diagnostic kit of colon cancer using colon cancer related marker, and diagnostic method therof
06/03/2010WO2010061981A1 Method for measuring cytokeratin-19 mrna
06/03/2010WO2010061930A1 IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN
06/03/2010WO2010061923A1 Amino acid sequence, dna, and enzyme producing method
06/03/2010WO2010061922A1 NOVEL MutS PROTEIN AND METHOD OF USING SAME TO DETERMINE MUTATIONS
06/03/2010WO2010061902A1 Screening method, composition containing substance selected by the screening method, and binding substance
06/03/2010WO2010061899A1 Transformed soybean plant which stores vaccine, and use thereof
06/03/2010WO2010061892A1 Novel variable lymphocyte receptor, method for screening for phage capable of binding to target antigen, and method for producing variable lymphocyte receptor for target antigen
06/03/2010WO2010061890A1 Process for producing l-amino acid
06/03/2010WO2010061881A1 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus
06/03/2010WO2010061781A1 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same
06/03/2010WO2010061697A1 Gene sensitive to normal-tension glaucoma disease, and use thereof
06/03/2010WO2010061638A1 Selection of target gene for anti-fungal agent, and method for predicting function of the target gene
06/03/2010WO2010061404A1 A method of expressing foreign protein in plastids
06/03/2010WO2010061393A1 He4 variant nucleotide and amino acid sequences, and methods of use thereof
06/03/2010WO2010061276A1 Method for producing male sterile plants
06/03/2010WO2010061215A1 Improvements in or relating to lipid content of plants
06/03/2010WO2010061203A1 Biocidal fusion peptide comprising ll-37
06/03/2010WO2010061187A2 Plant mitochondria transformation method
06/03/2010WO2010061186A2 Plant plastid transformation method
06/03/2010WO2010061181A1 Engineering of plants to exhibit self-incompatibility
06/03/2010WO2010060972A1 Erk1/2 phosphorylation site specific antibody
06/03/2010WO2010060964A2 Cellulase cel5h related reagents and their use in microorganisms
06/03/2010WO2010060934A2 Cnnm proteins and uses thereof
06/03/2010WO2010060844A1 Artificial chromosome vector
06/03/2010WO2010060719A1 Method for the production of adenoviral vectors
06/03/2010WO2010060632A1 Promoters for recombinant viral expression
06/03/2010WO2010060618A1 Monomeric variants of he tetrameric eqfp611
06/03/2010WO2010060609A1 Expression cassettes for seed-specific expression in plants
06/03/2010WO2010060507A1 Method for preparing high-throughput sequenceable dna from individual plaques of phages presenting peptides
06/03/2010WO2010060270A1 Novel strongly salt-tolerant gene nhxfs1 of plant, encoding protein and uses thereof
06/03/2010WO2010060200A1 Bacteriophage compositions for treatment of bacterial infections
06/03/2010WO2010060188A1 Hosts and fermentation processes for cellulase production
06/03/2010WO2010060186A1 Antibodies that specifically block the biological activity of a tumor antigen
06/03/2010WO2010060162A1 Use of at(n) insertions in promoter elements for controlling the expression levels of coding sequences in plants
06/03/2010WO2010060132A1 Method of cloning dna
06/03/2010WO2010036391A3 A novel rna-based expression system
06/03/2010WO2010036293A8 Malaria vaccine
06/03/2010WO2010035954A3 Vaccine composition for prevention or treatment of pneumococcal infections comprising vncr/s operon-disabled streptococcus pneumonia mutant strain or pep27 peptide
06/03/2010WO2010033247A3 Reduced size self-delivering rnai compounds
06/03/2010WO2010028366A3 Methods and systems for nucleic acid sequencing validation, calibration and normalization
06/03/2010WO2010027729A3 Gonococcal vaccines
06/03/2010WO2010025077A3 Genomic dna labeling and amplification
06/03/2010WO2010019838A3 Stress tolerant transgenic crop plants
06/03/2010WO2010017311A3 Nucleic acid compounds for inhibiting birc5 gene expression and uses thereof
06/03/2010WO2010011961A3 Prokaryotic rnai-like system and methods of use
1 ... 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 ... 4023